Recent Posts
- Cognetivity Neurosciences’ CognICA™ Platform Successfully Monitors Cognitive Performance in Alzheimer’s Patients Receiving Disease-Modifying Therapy
- Cognetivity Neurosciences Provides Update on 2022 Corporate Achievements
- Cognetivity Neurosciences’ Brain Health Platform Cited as Case Study as Part of Early Dementia Detection Policy Recommendations by Alzheimer’s Research UK
- Cognetivity Neurosciences to Attend HLTH 2022 in Las Vegas and Appoints New Advisory Board Member
- Cognetivity Neurosciences Selected to Present to Roche Alzheimer’s Team
Recent Comments